BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ananthakrishnan AN, Bernstein CN, Iliopoulos D, Macpherson A, Neurath MF, Ali RAR, Vavricka SR, Fiocchi C. Environmental triggers in IBD: a review of progress and evidence. Nat Rev Gastroenterol Hepatol. 2018;15:39-49. [PMID: 29018271 DOI: 10.1038/nrgastro.2017.136] [Cited by in Crossref: 220] [Cited by in F6Publishing: 205] [Article Influence: 44.0] [Reference Citation Analysis]
Number Citing Articles
1 Hasain Z, Mokhtar NM, Kamaruddin NA, Mohamed Ismail NA, Razalli NH, Gnanou JV, Raja Ali RA. Gut Microbiota and Gestational Diabetes Mellitus: A Review of Host-Gut Microbiota Interactions and Their Therapeutic Potential. Front Cell Infect Microbiol 2020;10:188. [PMID: 32500037 DOI: 10.3389/fcimb.2020.00188] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 10.0] [Reference Citation Analysis]
2 Xie F, Zhang H, Zheng C, Shen XF. Costunolide improved dextran sulfate sodium-induced acute ulcerative colitis in mice through NF-κB, STAT1/3, and Akt signaling pathways. Int Immunopharmacol 2020;84:106567. [PMID: 32413737 DOI: 10.1016/j.intimp.2020.106567] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
3 Iwatani S, Shinzaki S, Amano T, Otake Y, Tani M, Yoshihara T, Tsujii Y, Hayashi Y, Inoue T, Okuzaki D, Mizushima T, Miyoshi E, Iijima H, Takehara T. Oligosaccharide‐dependent anti‐inflammatory role of galectin‐1 for macrophages in ulcerative colitis. Journal of Gastroenterology and Hepatology 2020;35:2158-69. [DOI: 10.1111/jgh.15097] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
4 Gao T, Wang T, Wang Z, Cao J, Dong Y, Chen Y. Melatonin-mediated MT2 attenuates colitis induced by dextran sodium sulfate via PI3K/AKT/Nrf2/SIRT1/RORα/NF-κB signaling pathways. Int Immunopharmacol 2021;96:107779. [PMID: 34162146 DOI: 10.1016/j.intimp.2021.107779] [Reference Citation Analysis]
5 Kuprys PV, Cannon AR, Shieh J, Iftekhar N, Park SK, Eberhardt JM, Ding X, Choudhry MA. Alcohol decreases intestinal ratio of Lactobacillus to Enterobacteriaceae and induces hepatic immune tolerance in a murine model of DSS-colitis. Gut Microbes 2020;12:1-16. [PMID: 33180663 DOI: 10.1080/19490976.2020.1838236] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Wang R, Li H, Wu J, Cai Z, Li B, Ni H, Qiu X, Chen H, Liu W, Yang Z, Liu M, Hu J, Liang Y, Lan P, Han J, Mo W. Gut stem cell necroptosis by genome instability triggers bowel inflammation. Nature 2020;580:386-90. [DOI: 10.1038/s41586-020-2127-x] [Cited by in Crossref: 38] [Cited by in F6Publishing: 39] [Article Influence: 19.0] [Reference Citation Analysis]
7 Campmans-Kuijpers MJE, Dijkstra G. Food and Food Groups in Inflammatory Bowel Disease (IBD): The Design of the Groningen Anti-Inflammatory Diet (GrAID). Nutrients 2021;13:1067. [PMID: 33806061 DOI: 10.3390/nu13041067] [Reference Citation Analysis]
8 Kriaa A, Jablaoui A, Rhimi S, Soussou S, Mkaouar H, Mariaule V, Gruba N, Gargouri A, Maguin E, Lesner A, Rhimi M. SP-1, a Serine Protease from the Gut Microbiota, Influences Colitis and Drives Intestinal Dysbiosis in Mice. Cells 2021;10:2658. [PMID: 34685638 DOI: 10.3390/cells10102658] [Reference Citation Analysis]
9 Zhang M, Yang D, Yu H, Li Q. MicroRNA-497 inhibits inflammation in DSS-induced IBD model mice and lipopolysaccharide-induced RAW264.7 cells via Wnt/β-catenin pathway. Int Immunopharmacol 2021;101:108318. [PMID: 34775365 DOI: 10.1016/j.intimp.2021.108318] [Reference Citation Analysis]
10 Arab HH, Al-Shorbagy MY, Saad MA. Activation of autophagy and suppression of apoptosis by dapagliflozin attenuates experimental inflammatory bowel disease in rats: Targeting AMPK/mTOR, HMGB1/RAGE and Nrf2/HO-1 pathways. Chem Biol Interact 2021;335:109368. [PMID: 33412153 DOI: 10.1016/j.cbi.2021.109368] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 11.0] [Reference Citation Analysis]
11 Dowdell AS, Cartwright IM, Goldberg MS, Kostelecky R, Ross T, Welch N, Glover LE, Colgan SP. The HIF target ATG9A is essential for epithelial barrier function and tight junction biogenesis.Mol Biol Cell. 2020;31:2249-2258. [PMID: 32726170 DOI: 10.1091/mbc.E20-05-0291] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
12 Zhang W, Michalowski CB, Beloqui A. Oral Delivery of Biologics in Inflammatory Bowel Disease Treatment. Front Bioeng Biotechnol 2021;9:675194. [PMID: 34150733 DOI: 10.3389/fbioe.2021.675194] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Sugihara K, Kamada N. Diet-Microbiota Interactions in Inflammatory Bowel Disease. Nutrients 2021;13:1533. [PMID: 34062869 DOI: 10.3390/nu13051533] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
14 Caër C, Wick MJ. Human Intestinal Mononuclear Phagocytes in Health and Inflammatory Bowel Disease. Front Immunol 2020;11:410. [PMID: 32256490 DOI: 10.3389/fimmu.2020.00410] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 10.0] [Reference Citation Analysis]
15 Luo X, Villablanca EJ. Type 2 immunity in intestinal homeostasis and inflammatory bowel disease. Biochem Soc Trans 2021;49:2371-80. [PMID: 34581755 DOI: 10.1042/BST20210535] [Reference Citation Analysis]
16 Sun Y, Li L, Xie R, Wang B, Jiang K, Cao H. Stress Triggers Flare of Inflammatory Bowel Disease in Children and Adults. Front Pediatr 2019;7:432. [PMID: 31709203 DOI: 10.3389/fped.2019.00432] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 9.0] [Reference Citation Analysis]
17 Di Giovangiulio M, Rizzo A, Franzè E, Caprioli F, Facciotti F, Onali S, Favale A, Stolfi C, Fehling HJ, Monteleone G, Fantini MC. Tbet Expression in Regulatory T Cells Is Required to Initiate Th1-Mediated Colitis. Front Immunol 2019;10:2158. [PMID: 31572375 DOI: 10.3389/fimmu.2019.02158] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 6.0] [Reference Citation Analysis]
18 Chen H, Chen L, Wang X, Ge X, Sun L, Wang Z, Xu X, Song Y, Chen J, Deng Q, Xie H, Chen T, Chen Y, Ding K, Wu J, Wang J. Transgenic overexpression of ITGB6 in intestinal epithelial cells exacerbates dextran sulfate sodium-induced colitis in mice. J Cell Mol Med 2021;25:2679-90. [PMID: 33491282 DOI: 10.1111/jcmm.16297] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
19 Peppas S, Pansieri C, Piovani D, Danese S, Peyrin-Biroulet L, Tsantes AG, Brunetta E, Tsantes AE, Bonovas S. The Brain-Gut Axis: Psychological Functioning and Inflammatory Bowel Diseases. J Clin Med 2021;10:377. [PMID: 33498197 DOI: 10.3390/jcm10030377] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
20 Shapiro JM, de Zoete MR, Palm NW, Laenen Y, Bright R, Mallette M, Bu K, Bielecka AA, Xu F, Hurtado-Lorenzo A, Shah SA, Cho JH, LeLeiko NS, Sands BE, Flavell RA, Clemente JC. Immunoglobulin A Targets a Unique Subset of the Microbiota in Inflammatory Bowel Disease. Cell Host Microbe 2021;29:83-93.e3. [PMID: 33385335 DOI: 10.1016/j.chom.2020.12.003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
21 Lautenschlager SA, Fournier N, Biedermann L, Pittet V, Schreiner P, Misselwitz B, Scharl M, Rogler G, Siebenhüner AR. The Influence of Breastfeeding, Cesarean Section, Pet Animals, and Urbanization on the Development of Inflammatory Bowel Disease: Data from the Swiss IBD Cohort Study. Inflamm Intest Dis 2020;5:170-9. [PMID: 33313069 DOI: 10.1159/000509058] [Reference Citation Analysis]
22 Herman SM, Zaborniak K, Bernstein CN. Insight into Inflammatory Bowel Disease Pathogenesis: Is the Answer Blowing in the Wind? Inflamm Bowel Dis 2021:izab183. [PMID: 34473278 DOI: 10.1093/ibd/izab183] [Reference Citation Analysis]
23 Selin KA, Hedin CRH, Villablanca EJ. Immunological networks defining the heterogeneity of inflammatory bowel diseases. J Crohns Colitis 2021:jjab085. [PMID: 33959743 DOI: 10.1093/ecco-jcc/jjab085] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
24 Cao J, Zhang H, Yang Z, Zhao J, Ma H. Effect of dehydroepiandrosterone on the immune response and gut microbiota in dextran sulfate sodium-induced colitis mice. Mol Immunol 2020;118:60-72. [PMID: 31855808 DOI: 10.1016/j.molimm.2019.12.008] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
25 Outtier A, Ferrante M. Chronic Antibiotic-Refractory Pouchitis: Management Challenges. Clin Exp Gastroenterol 2021;14:277-90. [PMID: 34163205 DOI: 10.2147/CEG.S219556] [Reference Citation Analysis]
26 Atanasova K, Lotter T, Reindl W, Lis S. Multidimensional Assessment of Interoceptive Abilities, Emotion Processing and the Role of Early Life Stress in Inflammatory Bowel Diseases. Front Psychiatry 2021;12:680878. [PMID: 34248716 DOI: 10.3389/fpsyt.2021.680878] [Reference Citation Analysis]
27 Jiang P, Wu S, Luo Q, Zhao XM, Chen WH. Metagenomic Analysis of Common Intestinal Diseases Reveals Relationships among Microbial Signatures and Powers Multidisease Diagnostic Models. mSystems 2021;6:e00112-21. [PMID: 33947803 DOI: 10.1128/mSystems.00112-21] [Reference Citation Analysis]
28 Sabzevary-Ghahfarokhi M, Shohan M, Shirzad H, Rahimian G, Bagheri N, Soltani A, Deris F, Ghatreh-Samani M, Razmara E. The expression analysis of Fra-1 gene and IL-11 protein in Iranian patients with ulcerative colitis. BMC Immunol 2018;19:17. [PMID: 29914371 DOI: 10.1186/s12865-018-0257-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.8] [Reference Citation Analysis]
29 Lindoso L, Mondal K, Venkateswaran S, Somineni HK, Ballengee C, Walters TD, Griffiths A, Noe JD, Crandall W, Snapper S, Rabizadeh S, Rosh JR, LeLeiko N, Guthery S, Mack D, Kellermayer R, Gulati AS, Pfefferkorn MD, Moulton DE, Keljo D, Cohen S, Oliva-Hemker M, Heyman MB, Otley A, Baker SS, Evans JS, Kirschner BS, Patel AS, Ziring D, Stephens MC, Baldassano R, Dubinsky MC, Markowitz J, Denson LA, Hyams J, Kugathasan S, Ananthakrishnan AN. The Effect of Early-Life Environmental Exposures on Disease Phenotype and Clinical Course of Crohn's Disease in Children. Am J Gastroenterol 2018;113:1524-9. [PMID: 30267029 DOI: 10.1038/s41395-018-0239-9] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
30 Niu W, Dong Y, Fu Z, Lv J, Wang L, Zhang Z, Huo J, Ju J. Effects of molecular weight of chitosan on anti-inflammatory activity and modulation of intestinal microflora in an ulcerative colitis model. Int J Biol Macromol 2021:S0141-8130(21)02422-3. [PMID: 34748786 DOI: 10.1016/j.ijbiomac.2021.11.024] [Reference Citation Analysis]
31 Couvineau A, Voisin T, Nicole P, Gratio V, Blais A. Orexins: A promising target to digestive cancers, inflammation, obesity and metabolism dysfunctions. World J Gastroenterol 2021; 27(44): 7582-7596 [PMID: 34908800 DOI: 10.3748/wjg.v27.i44.7582] [Reference Citation Analysis]
32 Ruiz E, Penrose HM, Heller S, Nakhoul H, Baddoo M, Flemington EF, Kandil E, Savkovic SD. Bacterial TLR4 and NOD2 signaling linked to reduced mitochondrial energy function in active inflammatory bowel disease. Gut Microbes 2020;11:350-63. [PMID: 31063017 DOI: 10.1080/19490976.2019.1611152] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
33 Ermann J, Matmusaev M, Haley EK, Braun C, Jost F, Mayer-Wrangowski S, Hsiao P, Ting N, Li L, Terenzio D, Chime J, Lukas S, Patnaude L, Panzenbeck M, Csordas D, Zheng J, Mierz D, Simpson T, King FJ, Klimowicz AP, Mbow ML, Fine JS, Miller CA, Fogal SE, Byrne FR. The potent and selective RIPK2 inhibitor BI 706039 improves intestinal inflammation in the TRUC mouse model of inflammatory bowel disease. Am J Physiol Gastrointest Liver Physiol 2021;321:G500-12. [PMID: 34494462 DOI: 10.1152/ajpgi.00163.2021] [Reference Citation Analysis]
34 Ray G, Longworth MS. Epigenetics, DNA Organization, and Inflammatory Bowel Disease. Inflamm Bowel Dis 2019;25:235-47. [PMID: 30407525 DOI: 10.1093/ibd/izy330] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 9.5] [Reference Citation Analysis]
35 Chen M, Li Q, Cao N, Deng Y, Li L, Zhao Q, Wu M, Ye M. Profiling of histone 3 lysine 27 acetylation reveals its role in a chronic DSS-induced colitis mouse model. Mol Omics 2019;15:296-307. [PMID: 31147658 DOI: 10.1039/c9mo00070d] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
36 Oka A, Ishimura N, Ishihara S. A New Dawn for the Use of Artificial Intelligence in Gastroenterology, Hepatology and Pancreatology. Diagnostics (Basel) 2021;11:1719. [PMID: 34574060 DOI: 10.3390/diagnostics11091719] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
37 Chandrasekaran A, Molparia B, Akhtar E, Wang X, Lewis JD, Chang JT, Oliveira G, Torkamani A, Konijeti GG. The Autoimmune Protocol Diet Modifies Intestinal RNA Expression in Inflammatory Bowel Disease. Crohns Colitis 360 2019;1:otz016. [PMID: 32309803 DOI: 10.1093/crocol/otz016] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
38 Dowdell AS, Colgan SP. Metabolic Host-Microbiota Interactions in Autophagy and the Pathogenesis of Inflammatory Bowel Disease (IBD). Pharmaceuticals (Basel) 2021;14:708. [PMID: 34451805 DOI: 10.3390/ph14080708] [Reference Citation Analysis]
39 Ticho AL, Malhotra P, Dudeja PK, Gill RK, Alrefai WA. Bile Acid Receptors and Gastrointestinal Functions.Liver Res. 2019;3:31-39. [PMID: 32368358 DOI: 10.1016/j.livres.2019.01.001] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 6.7] [Reference Citation Analysis]
40 Weger BD, Rawashdeh O, Gachon F. At the Intersection of Microbiota and Circadian Clock: Are Sexual Dimorphism and Growth Hormones the Missing Link to Pathology?: Circadian Clock and Microbiota: Potential Egffect on Growth Hormone and Sexual Development. BioEssays 2019;41:1900059. [DOI: 10.1002/bies.201900059] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
41 Morey-Matamalas A, Denk D, Silina A, Stidworthy MF, Mätz-Rensing K, Bleyer M, Baiker K. Histopathological Characterization of Colitis in Captive Western Lowland Gorillas (Gorilla gorilla ssp gorilla). J Comp Pathol 2021;185:108-17. [PMID: 34119227 DOI: 10.1016/j.jcpa.2021.04.003] [Reference Citation Analysis]
42 Gianchecchi E, Fierabracci A. Recent Advances on Microbiota Involvement in the Pathogenesis of Autoimmunity. Int J Mol Sci. 2019;20. [PMID: 30642013 DOI: 10.3390/ijms20020283] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 7.7] [Reference Citation Analysis]
43 Jordi SBU, Botte F, Lang BM, Greuter T, Krupka N, Auschra B, Schreiner P, Sulz MC, Biedermann L, von Känel R, Rogler G, Begré S, Misselwitz B; Swiss IBD cohort study group. Type D personality is associated with depressive symptoms and clinical activity in inflammatory bowel disease. Aliment Pharmacol Ther 2021;54:53-67. [PMID: 33975385 DOI: 10.1111/apt.16365] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
44 Laing B, Barnett MPG, Marlow G, Nasef NA, Ferguson LR. An update on the role of gut microbiota in chronic inflammatory diseases, and potential therapeutic targets. Expert Rev Gastroenterol Hepatol. 2018;12:969-983. [PMID: 30052094 DOI: 10.1080/17474124.2018.1505497] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
45 Ahmad A, Ansari MM, Kumar A, Bishnoi M, Raza SS, Khan R. Aminocellulose - grafted polycaprolactone-coated core-shell nanoparticles alleviate the severity of ulcerative colitis: a novel adjuvant therapeutic approach. Biomater Sci 2021;9:5868-83. [PMID: 34286723 DOI: 10.1039/d1bm00877c] [Reference Citation Analysis]
46 Qv L, Mao S, Li Y, Zhang J, Li L. Roles of Gut Bacteriophages in the Pathogenesis and Treatment of Inflammatory Bowel Disease. Front Cell Infect Microbiol 2021;11:755650. [PMID: 34900751 DOI: 10.3389/fcimb.2021.755650] [Reference Citation Analysis]
47 Xie R, Sun Y, Wu J, Huang S, Jin G, Guo Z, Zhang Y, Liu T, Liu X, Cao X, Wang B, Cao H. Maternal High Fat Diet Alters Gut Microbiota of Offspring and Exacerbates DSS-Induced Colitis in Adulthood. Front Immunol 2018;9:2608. [PMID: 30483266 DOI: 10.3389/fimmu.2018.02608] [Cited by in Crossref: 32] [Cited by in F6Publishing: 27] [Article Influence: 8.0] [Reference Citation Analysis]
48 Wilson SS, Mayo M, Melim T, Knight H, Patnaude L, Wu X, Phillips L, Westmoreland S, Dunstan R, Fiebiger E, Terrillon S. Optimized Culture Conditions for Improved Growth and Functional Differentiation of Mouse and Human Colon Organoids. Front Immunol 2020;11:547102. [PMID: 33643277 DOI: 10.3389/fimmu.2020.547102] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
49 Sandes S, Figueiredo N, Pedroso S, Sant'Anna F, Acurcio L, Abatemarco Junior M, Barros P, Oliveira F, Cardoso V, Generoso S, Caliari M, Nicoli J, Neumann E, Nunes Á. Weissella paramesenteroides WpK4 plays an immunobiotic role in gut-brain axis, reducing gut permeability, anxiety-like and depressive-like behaviors in murine models of colitis and chronic stress. Food Res Int 2020;137:109741. [PMID: 33233306 DOI: 10.1016/j.foodres.2020.109741] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
50 Trivedi PJ, Hirschfield GM. Recent advances in clinical practice: epidemiology of autoimmune liver diseases. Gut 2021:gutjnl-2020-322362. [PMID: 34266966 DOI: 10.1136/gutjnl-2020-322362] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
51 Silvestri C, Pagano E, Lacroix S, Venneri T, Cristiano C, Calignano A, Parisi OA, Izzo AA, Di Marzo V, Borrelli F. Fish Oil, Cannabidiol and the Gut Microbiota: An Investigation in a Murine Model of Colitis. Front Pharmacol 2020;11:585096. [PMID: 33162890 DOI: 10.3389/fphar.2020.585096] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
52 Roda G, Chien Ng S, Kotze PG, Argollo M, Panaccione R, Spinelli A, Kaser A, Peyrin-Biroulet L, Danese S. Crohn's disease.Nat Rev Dis Primers. 2020;6:22. [PMID: 32242028 DOI: 10.1038/s41572-020-0156-2] [Cited by in Crossref: 47] [Cited by in F6Publishing: 37] [Article Influence: 23.5] [Reference Citation Analysis]
53 Li X, Sun H, Li B, Zhang X, Cui J, Yun J, Yang Y, Zhang L, Meng Q, Wu S, Duan J, Yang H, Wu J, Sun Z, Zou Y, Chen R. Probiotics Ameliorate Colon Epithelial Injury Induced by Ambient Ultrafine Particles Exposure. Adv Sci (Weinh) 2019;6:1900972. [PMID: 31559135 DOI: 10.1002/advs.201900972] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
54 Diefenbach A, Gnafakis S, Shomrat O. Innate Lymphoid Cell-Epithelial Cell Modules Sustain Intestinal Homeostasis. Immunity 2020;52:452-63. [PMID: 32187516 DOI: 10.1016/j.immuni.2020.02.016] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 9.0] [Reference Citation Analysis]
55 Xu F, Cheng Y, Ruan G, Fan L, Tian Y, Xiao Z, Chen D, Wei Y. New pathway ameliorating ulcerative colitis: focus on Roseburia intestinalis and the gut-brain axis. Therap Adv Gastroenterol 2021;14:17562848211004469. [PMID: 33948112 DOI: 10.1177/17562848211004469] [Reference Citation Analysis]
56 Manzini R, Schwarzfischer M, Bircher A, Niechcial A, Vavricka SR, Atrott K, Lang S, Scharl M, Spalinger MR. Energy Drink Administration Ameliorates Intestinal Epithelial Barrier Defects and Reduces Acute DSS Colitis. Inflamm Bowel Dis 2021;27:1139-52. [PMID: 33501991 DOI: 10.1093/ibd/izaa328] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
57 Dujardin CE, Mars RAT, Manemann SM, Kashyap PC, Clements NS, Hassett LC, Roger VL. Impact of air quality on the gastrointestinal microbiome: A review. Environ Res 2020;186:109485. [PMID: 32289569 DOI: 10.1016/j.envres.2020.109485] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
58 Yan Z, Liu Y, Zhang T, Zhang F, Ren H, Zhang Y. Analysis of Microplastics in Human Feces Reveals a Correlation between Fecal Microplastics and Inflammatory Bowel Disease Status. Environ Sci Technol 2021. [PMID: 34935363 DOI: 10.1021/acs.est.1c03924] [Reference Citation Analysis]
59 Zou J, Liu C, Jiang S, Qian D, Duan J. Cross Talk between Gut Microbiota and Intestinal Mucosal Immunity in the Development of Ulcerative Colitis. Infect Immun 2021;89:e0001421. [PMID: 33526559 DOI: 10.1128/IAI.00014-21] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
60 Roosenboom B, Wahab PJ, Smids C, Groenen MJM, van Koolwijk E, van Lochem EG, Horjus Talabur Horje CS. Intestinal CD103+CD4+ and CD103+CD8+ T-Cell Subsets in the Gut of Inflammatory Bowel Disease Patients at Diagnosis and During Follow-up. Inflamm Bowel Dis 2019;25:1497-509. [PMID: 30918941 DOI: 10.1093/ibd/izz049] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 7.0] [Reference Citation Analysis]
61 Zundler S, Becker E, Schulze LL, Neurath MF. Immune cell trafficking and retention in inflammatory bowel disease: mechanistic insights and therapeutic advances. Gut 2019;68:1688-700. [DOI: 10.1136/gutjnl-2018-317977] [Cited by in Crossref: 41] [Cited by in F6Publishing: 34] [Article Influence: 13.7] [Reference Citation Analysis]
62 Schreiber S, Colombel JF, Feagan BG, Reich K, Deodhar AA, McInnes IB, Porter B, Das Gupta A, Pricop L, Fox T. Incidence rates of inflammatory bowel disease in patients with psoriasis, psoriatic arthritis and ankylosing spondylitis treated with secukinumab: a retrospective analysis of pooled data from 21 clinical trials. Ann Rheum Dis. 2019;78:473-479. [PMID: 30674475 DOI: 10.1136/annrheumdis-2018-214273] [Cited by in Crossref: 72] [Cited by in F6Publishing: 65] [Article Influence: 24.0] [Reference Citation Analysis]
63 Ananthakrishnan AN, Kaplan GG, Ng SC. Changing Global Epidemiology of Inflammatory Bowel Diseases: Sustaining Health Care Delivery Into the 21st Century. Clinical Gastroenterology and Hepatology 2020;18:1252-60. [DOI: 10.1016/j.cgh.2020.01.028] [Cited by in Crossref: 38] [Cited by in F6Publishing: 39] [Article Influence: 19.0] [Reference Citation Analysis]
64 Cai C, Zhu S, Tong J, Wang T, Feng Q, Qiao Y, Shen J. Relating the transcriptome and microbiome by paired terminal ileal Crohn disease. iScience 2021;24:102516. [PMID: 34113837 DOI: 10.1016/j.isci.2021.102516] [Reference Citation Analysis]
65 Diab J, Hansen T, Goll R, Stenlund H, Ahnlund M, Jensen E, Moritz T, Florholmen J, Forsdahl G. Lipidomics in Ulcerative Colitis Reveal Alteration in Mucosal Lipid Composition Associated With the Disease State. Inflammatory Bowel Diseases 2019;25:1780-7. [DOI: 10.1093/ibd/izz098] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
66 Sun Y, Xie R, Li L, Jin G, Zhou B, Huang H, Li M, Yang Y, Liu X, Cao X, Wang B, Liu W, Jiang K, Cao H. Prenatal Maternal Stress Exacerbates Experimental Colitis of Offspring in Adulthood. Front Immunol 2021;12:700995. [PMID: 34804005 DOI: 10.3389/fimmu.2021.700995] [Reference Citation Analysis]
67 Dvornikova KA, Bystrova EY, Churilov LP, Lerner A. Pathogenesis of the inflammatory bowel disease in context of SARS-COV-2 infection. Mol Biol Rep 2021;48:5745-58. [PMID: 34296352 DOI: 10.1007/s11033-021-06565-w] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
68 Yang WH, Westman JS, Heithoff DM, Sperandio M, Cho JW, Mahan MJ, Marth JD. Neu3 neuraminidase induction triggers intestinal inflammation and colitis in a model of recurrent human food-poisoning. Proc Natl Acad Sci U S A 2021;118:e2100937118. [PMID: 34266954 DOI: 10.1073/pnas.2100937118] [Reference Citation Analysis]
69 Nadeem MS, Kumar V, Al-abbasi FA, Kamal MA, Anwar F. Risk of colorectal cancer in inflammatory bowel diseases. Seminars in Cancer Biology 2020;64:51-60. [DOI: 10.1016/j.semcancer.2019.05.001] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 14.5] [Reference Citation Analysis]
70 Danielsen EM, De Haro Hernando A, Yassin M, Rasmussen K, Olsen J, Hansen GH, Danielsen EM. Short-term tissue permeability actions of dextran sulfate sodium studied in a colon organ culture system. Tissue Barriers 2020;8:1728165. [PMID: 32079482 DOI: 10.1080/21688370.2020.1728165] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
71 Cao SS. Cellular Stress Responses and Gut Microbiota in Inflammatory Bowel Disease. Gastroenterol Res Pract. 2018;2018:7192646. [PMID: 30026758 DOI: 10.1155/2018/7192646] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
72 Rapa SF, Di Paola R, Cordaro M, Siracusa R, D'Amico R, Fusco R, Autore G, Cuzzocrea S, Stuppner H, Marzocco S. Plumericin Protects against Experimental Inflammatory Bowel Disease by Restoring Intestinal Barrier Function and Reducing Apoptosis. Biomedicines 2021;9:67. [PMID: 33445622 DOI: 10.3390/biomedicines9010067] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
73 Chen T, Wang R, Duan Z, Yuan X, Ding Y, Feng Z, Bu F, Liu L, Wang Q, Zhou J, Zhu L, Ni Q, Shi G, Chen Y. Akkermansia muciniphila Protects Against Psychological Disorder-Induced Gut Microbiota-Mediated Colonic Mucosal Barrier Damage and Aggravation of Colitis. Front Cell Infect Microbiol 2021;11:723856. [PMID: 34722332 DOI: 10.3389/fcimb.2021.723856] [Reference Citation Analysis]
74 Zeng W, He D, Xing Y, Liu J, Su N, Zhang C, Wang Y, Xing X. Internal connections between dietary intake and gut microbiota homeostasis in disease progression of ulcerative colitis: a review. Food Science and Human Wellness 2021;10:119-30. [DOI: 10.1016/j.fshw.2021.02.016] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
75 Mokhtar NM, Nawawi KNM, Verasingam J, Zhiqin W, Sagap I, Azman ZAM, Mazlan L, Hamid HA, Yaacob NY, Rose IM, Den ELN, Wan MS, Raja Ali RA. A four-decade analysis of the incidence trends, sociodemographic and clinical characteristics of inflammatory bowel disease patients at single tertiary centre, Kuala Lumpur, Malaysia. BMC Public Health 2019;19:550. [PMID: 31196184 DOI: 10.1186/s12889-019-6858-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
76 Brockway-lunardi L, Nelson S, Pandiri AR, Tricoli JV, Umar A, Wali A, Daschner PJ. Early-onset colorectal cancer research: gaps and opportunities. Colorectal Cancer 2020;9:CRC34. [DOI: 10.2217/crc-2020-0028] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 2.5] [Reference Citation Analysis]
77 Garcia-Carbonell R, Yao SJ, Das S, Guma M. Dysregulation of Intestinal Epithelial Cell RIPK Pathways Promotes Chronic Inflammation in the IBD Gut. Front Immunol 2019;10:1094. [PMID: 31164887 DOI: 10.3389/fimmu.2019.01094] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 6.7] [Reference Citation Analysis]
78 Avalos DJ, Satiya J, Contreras A, Trivedi S, Alvarado L, Dodoo C, Dwivedi AK, Zuckerman MJ. Latin Americans and US Hispanics show differences in IBD phenotype: a systematic review with meta-analysis. J Investig Med 2021:jim-2021-001846. [PMID: 34933995 DOI: 10.1136/jim-2021-001846] [Reference Citation Analysis]
79 Arnone D, Vallier M, Hergalant S, Chabot C, Ndiaye NC, Moulin D, Aignatoaei AM, Alberto JM, Louis H, Boulard O, Mayeur C, Dreumont N, Peuker K, Strigli A, Zeissig S, Hansmannel F, Chamaillard M, Kökten T, Peyrin-Biroulet L. Long-Term Overconsumption of Fat and Sugar Causes a Partially Reversible Pre-inflammatory Bowel Disease State. Front Nutr 2021;8:758518. [PMID: 34869528 DOI: 10.3389/fnut.2021.758518] [Reference Citation Analysis]
80 Friedman S, Nørgård BM. Confirming Complexity: Assessing Environmental and Genetic Risk Factors for Inflammatory Bowel Disease. Gastroenterology 2019;156:2124-5. [PMID: 31034830 DOI: 10.1053/j.gastro.2019.04.030] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
81 Yan JB, Luo MM, Chen ZY, He BH. The Function and Role of the Th17/Treg Cell Balance in Inflammatory Bowel Disease. J Immunol Res 2020;2020:8813558. [PMID: 33381606 DOI: 10.1155/2020/8813558] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
82 Ahmad A, Ansari MM, Mishra RK, Kumar A, Vyawahare A, Verma RK, Raza SS, Khan R. Enteric-coated gelatin nanoparticles mediated oral delivery of 5-aminosalicylic acid alleviates severity of DSS-induced ulcerative colitis. Materials Science and Engineering: C 2021;119:111582. [DOI: 10.1016/j.msec.2020.111582] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
83 Liu W, Dong Z, Liu K, Lu Y, Wu W, Qi J, Chen Z. Targeting strategies of oral nano-delivery systems for treating inflammatory bowel disease. Int J Pharm 2021;600:120461. [PMID: 33711470 DOI: 10.1016/j.ijpharm.2021.120461] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
84 Chen F, Yin YT, Zhao HM, Wang HY, Zhong YB, Long J, Liu DY. Sishen Pill Treatment of DSS-Induced Colitis via Regulating Interaction With Inflammatory Dendritic Cells and Gut Microbiota. Front Physiol 2020;11:801. [PMID: 32754049 DOI: 10.3389/fphys.2020.00801] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
85 Dubinsky V, Reshef L, Rabinowitz K, Yadgar K, Godny L, Zonensain K, Wasserberg N, Dotan I, Gophna U. Dysbiosis in Metabolic Genes of the Gut Microbiomes of Patients with an Ileo-anal Pouch Resembles That Observed in Crohn's Disease. mSystems 2021;6:e00984-20. [PMID: 33653942 DOI: 10.1128/mSystems.00984-20] [Reference Citation Analysis]
86 Lufton M, Bustan O, Eylon B, Shtifman-segal E, Croitoru-sadger T, Shagan A, Shabtay-orbach A, Corem-salkmon E, Berman J, Nyska A, Mizrahi B. Living Bacteria in Thermoresponsive Gel for Treating Fungal Infections. Adv Funct Mater 2018;28:1801581. [DOI: 10.1002/adfm.201801581] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 2.8] [Reference Citation Analysis]
87 Popov J, Caputi V, Nandeesha N, Rodriguez DA, Pai N. Microbiota-Immune Interactions in Ulcerative Colitis and Colitis Associated Cancer and Emerging Microbiota-Based Therapies. Int J Mol Sci 2021;22:11365. [PMID: 34768795 DOI: 10.3390/ijms222111365] [Reference Citation Analysis]
88 Meng X, Zhou HY, Shen HH, Lufumpa E, Li XM, Guo B, Li BZ. Microbe-metabolite-host axis, two-way action in the pathogenesis and treatment of human autoimmunity. Autoimmun Rev 2019;18:455-75. [PMID: 30844549 DOI: 10.1016/j.autrev.2019.03.006] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 6.7] [Reference Citation Analysis]
89 Meriwether D, Sulaiman D, Volpe C, Dorfman A, Grijalva V, Dorreh N, Solorzano-Vargas RS, Wang J, O'Connor E, Papesh J, Larauche M, Trost H, Palgunachari MN, Anantharamaiah GM, Herschman HR, Martin MG, Fogelman AM, Reddy ST. Apolipoprotein A-I mimetics mitigate intestinal inflammation in COX2-dependent inflammatory bowel disease model. J Clin Invest 2019;129:3670-85. [PMID: 31184596 DOI: 10.1172/JCI123700] [Cited by in Crossref: 28] [Cited by in F6Publishing: 18] [Article Influence: 9.3] [Reference Citation Analysis]
90 Chen JA, Ma H, Liu Z, Tian J, Lu S, Fang W, Ze S, Lu W, Xie Q, Huang J, Wang Y. Discovery of Orally Available Retinoic Acid Receptor-Related Orphan Receptor γ-t/Dihydroorotate Dehydrogenase Dual Inhibitors for the Treatment of Refractory Inflammatory Bowel Disease. J Med Chem 2021. [PMID: 34957834 DOI: 10.1021/acs.jmedchem.1c01746] [Reference Citation Analysis]
91 Magalhães DDA, Sousa SG, de Sousa AK, Vasconcelos DFP, Barbosa ALDR. Cannabinoid agonists possibly mediate interaction between cholinergic and cannabinoid systems in regulating intestinal inflammation. Medical Hypotheses 2020;139:109613. [DOI: 10.1016/j.mehy.2020.109613] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
92 Borg-Bartolo SP, Boyapati RK, Satsangi J, Kalla R. Precision medicine in inflammatory bowel disease: concept, progress and challenges. F1000Res. 2020;9. [PMID: 32047622 DOI: 10.12688/f1000research.20928.1] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 7.0] [Reference Citation Analysis]
93 Sun Q, Du M, Kang Y, Zhu MJ. Prebiotic effects of goji berry in protection against inflammatory bowel disease. Crit Rev Food Sci Nutr 2022;:1-25. [PMID: 34991393 DOI: 10.1080/10408398.2021.2015680] [Reference Citation Analysis]
94 Hou S, Yang X, Tong Y, Yang Y, Chen Q, Wan B, Wei R, Wang Y, Zhang Y, Kong B, Huang J, Chen Y, Lu T, Hu Q, Du D. Structure-based discovery of 1H-indole-2-carboxamide derivatives as potent ASK1 inhibitors for potential treatment of ulcerative colitis. Eur J Med Chem 2021;211:113114. [PMID: 33360793 DOI: 10.1016/j.ejmech.2020.113114] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
95 Decara J, Rivera P, López-Gambero AJ, Serrano A, Pavón FJ, Baixeras E, Rodríguez de Fonseca F, Suárez J. Peroxisome Proliferator-Activated Receptors: Experimental Targeting for the Treatment of Inflammatory Bowel Diseases. Front Pharmacol 2020;11:730. [PMID: 32536865 DOI: 10.3389/fphar.2020.00730] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
96 Park SH, Kim J, Moon Y. Caveolar communication with xenobiotic-stalled ribosomes compromises gut barrier integrity. Commun Biol 2020;3:270. [PMID: 32461676 DOI: 10.1038/s42003-020-0994-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
97 Conde J, Schwarzfischer M, Katkeviciute E, Häfliger J, Niechcial A, Brillant N, Manzini R, Bäbler K, Atrott K, Lang S, Scharl M. Titanium Dioxide Presents a Different Profile in Dextran Sodium Sulphate-Induced Experimental Colitis in Mice Lacking the IBD Risk Gene Ptpn2 in Myeloid Cells. Int J Mol Sci 2021;22:E772. [PMID: 33466682 DOI: 10.3390/ijms22020772] [Reference Citation Analysis]
98 Song Y, Zhao Y, Ma Y, Wang Z, Rong L, Wang B, Zhang N. Biological functions of NLRP3 inflammasome: A therapeutic target in inflammatory bowel disease. Cytokine Growth Factor Rev 2021;60:61-75. [PMID: 33773897 DOI: 10.1016/j.cytogfr.2021.03.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
99 Kim JK, Choi MS, Kim JY, Yu JS, Seo JI, Yoo HH, Kim DH. Ginkgo biloba leaf extract suppresses intestinal human breast cancer resistance protein expression in mice: Correlation with gut microbiota. Biomed Pharmacother 2021;140:111712. [PMID: 34010745 DOI: 10.1016/j.biopha.2021.111712] [Reference Citation Analysis]
100 Carvalho AL, Hedrich CM. The Molecular Pathophysiology of Psoriatic Arthritis-The Complex Interplay Between Genetic Predisposition, Epigenetics Factors, and the Microbiome. Front Mol Biosci 2021;8:662047. [PMID: 33869291 DOI: 10.3389/fmolb.2021.662047] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
101 Sebbagh AC, Rosenbaum B, Péré G, Alric H, Berger A, Wilhelm C, Gazeau F, Mathieu N, Rahmi G, Silva AKA. Regenerative medicine for digestive fistulae therapy: Benefits, challenges and promises of stem/stromal cells and emergent perspectives via their extracellular vesicles. Adv Drug Deliv Rev 2021;:113841. [PMID: 34175308 DOI: 10.1016/j.addr.2021.113841] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
102 Ren J, Yue B, Wang H, Zhang B, Luo X, Yu Z, Zhang J, Ren Y, Mani S, Wang Z, Dou W. Acacetin Ameliorates Experimental Colitis in Mice via Inhibiting Macrophage Inflammatory Response and Regulating the Composition of Gut Microbiota. Front Physiol 2020;11:577237. [PMID: 33536931 DOI: 10.3389/fphys.2020.577237] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
103 Coates MD, Ba DM, Liu G, Dalessio S, Leslie DL, Huang X. Revisiting the Association Between Inflammatory Bowel Disease and Parkinson's Disease. Inflamm Bowel Dis 2021:izab175. [PMID: 34259840 DOI: 10.1093/ibd/izab175] [Reference Citation Analysis]
104 Linares R, Fernández MF, Gutiérrez A, García-Villalba R, Suárez B, Zapater P, Martínez-Blázquez JA, Caparrós E, Tomás-Barberán FA, Francés R. Endocrine disruption in Crohn's disease: Bisphenol A enhances systemic inflammatory response in patients with gut barrier translocation of dysbiotic microbiota products. FASEB J 2021;35:e21697. [PMID: 34085740 DOI: 10.1096/fj.202100481R] [Reference Citation Analysis]
105 Saberzadeh-Ardestani B, Anushiravani A, Mansour-Ghanaei F, Fakheri H, Vahedi H, Sheikhesmaeili F, Yazdanbod A, Moosavy SH, Vosoghinia H, Maleki I, Nasseri-Moghaddam S, Khosravi B, Malekzadeh M, Kasaeian A, Alatab S, Sadeghi A, Kolahdoozan S, Rayatpisheh M, Sima AR, Malekzadeh R. Clinical Phenotype and Disease Course of Inflammatory Bowel Disease: A Comparison Between Sporadic and Familial Cases. Inflamm Bowel Dis 2021:izab202. [PMID: 34417824 DOI: 10.1093/ibd/izab202] [Reference Citation Analysis]
106 Wu Y, Pei C, Wang X, Wang M, Huang D, Wang F, Xiao W, Wang Z. Effect of probiotics on nasal and intestinal microbiota in people with high exposure to particulate matter ≤ 2.5 μm (PM2.5): a randomized, double-blind, placebo-controlled clinical study. Trials 2020;21:850. [PMID: 33054842 DOI: 10.1186/s13063-020-04759-4] [Reference Citation Analysis]
107 Jang HM, Kim JK, Joo MK, Shin YJ, Lee CK, Kim HJ, Kim DH. Transplantation of fecal microbiota from patients with inflammatory bowel disease and depression alters immune response and behavior in recipient mice. Sci Rep 2021;11:20406. [PMID: 34650107 DOI: 10.1038/s41598-021-00088-x] [Reference Citation Analysis]
108 Cruz-Lebrón A, D'argenio Garcia L, Talla A, Joussef-Piña S, Quiñones-Mateu ME, Sékaly RP, de Carvalho KIL, Levine AD. Decreased Enteric Bacterial Composition and Diversity in South American Crohn's Disease Vary With the Choice of Treatment Strategy and Time Since Diagnosis. J Crohns Colitis 2020;14:791-800. [PMID: 31758685 DOI: 10.1093/ecco-jcc/jjz189] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
109 Nielsen TS, Fredborg M, Theil PK, Yue Y, Bruhn LV, Andersen V, Purup S. Dietary Red Meat Adversely Affects Disease Severity in a Pig Model of DSS-Induced Colitis Despite Reduction in Colonic Pro-Inflammatory Gene Expression. Nutrients 2020;12:E1728. [PMID: 32526985 DOI: 10.3390/nu12061728] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
110 Tang B, Zhu J, Zhang B, Wu F, Wang Y, Weng Q, Fang S, Zheng L, Yang Y, Qiu R, Chen M, Xu M, Zhao Z, Ji J. Therapeutic Potential of Triptolide as an Anti-Inflammatory Agent in Dextran Sulfate Sodium-Induced Murine Experimental Colitis. Front Immunol 2020;11:592084. [PMID: 33240279 DOI: 10.3389/fimmu.2020.592084] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
111 Yue B, Luo X, Yu Z, Mani S, Wang Z, Dou W. Inflammatory Bowel Disease: A Potential Result from the Collusion between Gut Microbiota and Mucosal Immune System. Microorganisms. 2019;7:440. [PMID: 31614539 DOI: 10.3390/microorganisms7100440] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 6.3] [Reference Citation Analysis]
112 Gonçalves BP, Flauzino T, Inoue CJ, de Paula JCC, Galvão TC, de Alcantara CC, Miyazaki PK, Rosa L, Westmore S, Lozovoy MAB, Reiche EMV, Simão ANC. IL6 genetic variants haplotype is associated with susceptibility and disease activity but not with therapy response in patients with inflammatory bowel disease. Int J Colorectal Dis 2021;36:383-93. [PMID: 33047210 DOI: 10.1007/s00384-020-03743-3] [Reference Citation Analysis]
113 Štambuk T, Klasić M, Zoldoš V, Lauc G. N-glycans as functional effectors of genetic and epigenetic disease risk. Mol Aspects Med 2021;79:100891. [PMID: 32861467 DOI: 10.1016/j.mam.2020.100891] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
114 Sandberg K, Yarger E, Saeed S. Updates in diagnosis and management of inflammatory bowel disease.Curr Probl Pediatr Adolesc Health Care. 2020;50:100785. [PMID: 32402535 DOI: 10.1016/j.cppeds.2020.100785] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
115 Bednarikova H, Kascakova N, Furstova J, Zelinkova Z, Falt P, Hasto J, Tavel P. Life Stressors in Patients with Inflammatory Bowel Disease: Comparison with a Population-Based Healthy Control Group in the Czech Republic. Int J Environ Res Public Health 2021;18:3237. [PMID: 33800985 DOI: 10.3390/ijerph18063237] [Reference Citation Analysis]
116 Ahmad W, Nguyen NH, Boland BS, Dulai PS, Pride DT, Bouland D, Sandborn WJ, Singh S. Comparison of Multiplex Gastrointestinal Pathogen Panel and Conventional Stool Testing for Evaluation of Diarrhea in Patients with Inflammatory Bowel Diseases. Dig Dis Sci 2019;64:382-90. [PMID: 30361807 DOI: 10.1007/s10620-018-5330-y] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
117 Zou M, Zeng QS, Nie J, Yang JH, Luo ZY, Gan HT. The Role of E3 Ubiquitin Ligases and Deubiquitinases in Inflammatory Bowel Disease: Friend or Foe? Front Immunol 2021;12:769167. [PMID: 34956195 DOI: 10.3389/fimmu.2021.769167] [Reference Citation Analysis]
118 Chiba M, Nakane K, Komatsu M. Westernized Diet is the Most Ubiquitous Environmental Factor in Inflammatory Bowel Disease. Perm J. 2019;23:18-107. [PMID: 30624192 DOI: 10.7812/tpp/18-107] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 5.0] [Reference Citation Analysis]
119 Onali S, Favale A, Fantini MC. The Resolution of Intestinal Inflammation: The Peace-Keeper's Perspective. Cells 2019;8:E344. [PMID: 30979024 DOI: 10.3390/cells8040344] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
120 Huai M, Zeng J, Ge W. Artemisinin ameliorates intestinal inflammation by skewing macrophages to the M2 phenotype and inhibiting epithelial-mesenchymal transition. Int Immunopharmacol 2021;91:107284. [PMID: 33359851 DOI: 10.1016/j.intimp.2020.107284] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
121 Belforte FS, Fernandez N, Tonín Monzón F, Rosso AD, Quesada S, Cimolai MC, Millán A, Cerrone GE, Frechtel GD, Burcelin R, Coluccio Leskow F, Penas-Steinhardt A. Getting to Know the Gut Microbial Diversity of Metropolitan Buenos Aires Inhabitants. Front Microbiol 2019;10:965. [PMID: 31164869 DOI: 10.3389/fmicb.2019.00965] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
122 Keshteli AH, Madsen KL, Dieleman LA. Diet in the Pathogenesis and Management of Ulcerative Colitis; A Review of Randomized Controlled Dietary Interventions. Nutrients 2019;11:E1498. [PMID: 31262022 DOI: 10.3390/nu11071498] [Cited by in Crossref: 21] [Cited by in F6Publishing: 13] [Article Influence: 7.0] [Reference Citation Analysis]
123 Xia Y, Tian LM, Liu Y, Guo KS, Lv M, Li QT, Hao SY, Ma CH, Chen YX, Tanaka M, Bai WB, Qiu CH. Low Dose of Cyanidin-3-O-Glucoside Alleviated Dextran Sulfate Sodium-Induced Colitis, Mediated by CD169+ Macrophage Pathway. Inflamm Bowel Dis 2019;25:1510-21. [PMID: 31107535 DOI: 10.1093/ibd/izz090] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
124 Kuhnen A. Genetic and Environmental Considerations for Inflammatory Bowel Disease. Surgical Clinics of North America 2019;99:1197-207. [DOI: 10.1016/j.suc.2019.08.014] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 4.7] [Reference Citation Analysis]
125 Zheng L, Wen XL. Gut microbiota and inflammatory bowel disease: The current status and perspectives. World J Clin Cases 2021; 9(2): 321-333 [PMID: 33521100 DOI: 10.12998/wjcc.v9.i2.321] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
126 Yin J, Tong F, Ye Y, Hu T, Xu L, Zhang L, Zhu J, Pang Z. Hsa_circRNA_103124 Upregulation in Crohn's Disease Promotes Cell Proliferation and Inhibits Autophagy by Regulating the Hsa-miR-650/AKT2 Signaling Pathway. Front Genet 2021;12:753161. [PMID: 34804121 DOI: 10.3389/fgene.2021.753161] [Reference Citation Analysis]
127 Xiong Y, Deng Z, Liu J, Qiu J, Guo L, Feng P, Sui J, Chen D, Guo H. Enhancement of epithelial cell autophagy induced by sinensetin alleviates epithelial barrier dysfunction in colitis. Pharmacological Research 2019;148:104461. [DOI: 10.1016/j.phrs.2019.104461] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
128 Pasvol TJ, Bloom S, Segal AW, Rait G, Horsfall L. Use of contraceptives and risk of inflammatory bowel disease: A nested case-control study. Aliment Pharmacol Ther 2021. [PMID: 34662440 DOI: 10.1111/apt.16647] [Reference Citation Analysis]
129 Sabzevary-ghahfarokhi M, Shohan M, Shirzad H, Rahimian G, Soltani A, Ghatreh-samani M, Deris F, Bagheri N, Shafigh M, Tahmasbi K. The regulatory role of Nrf2 in antioxidants phase2 enzymes and IL-17A expression in patients with ulcerative colitis. Pathology - Research and Practice 2018;214:1149-55. [DOI: 10.1016/j.prp.2018.06.001] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
130 Mendall MA, Jensen CB, Sørensen TIA, Ängquist LH, Jess T. Body mass index in young men and risk of inflammatory bowel disease through adult life: A population-based Danish cohort study. Sci Rep 2019;9:6360. [PMID: 31015530 DOI: 10.1038/s41598-019-42642-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
131 Knox NC, Forbes JD, Peterson CL, Van Domselaar G, Bernstein CN. The Gut Microbiome in Inflammatory Bowel Disease: Lessons Learned From Other Immune-Mediated Inflammatory Diseases. Am J Gastroenterol. 2019;114:1051-1070. [PMID: 31232832 DOI: 10.14309/ajg.0000000000000305] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 8.5] [Reference Citation Analysis]
132 Wang L, Gao M, Kang G, Huang H. The Potential Role of Phytonutrients Flavonoids Influencing Gut Microbiota in the Prophylaxis and Treatment of Inflammatory Bowel Disease. Front Nutr 2021;8:798038. [PMID: 34970585 DOI: 10.3389/fnut.2021.798038] [Reference Citation Analysis]
133 Bai X, Narayanan A, Nowak P, Ray S, Neogi U, Sönnerborg A. Whole-Genome Metagenomic Analysis of the Gut Microbiome in HIV-1-Infected Individuals on Antiretroviral Therapy. Front Microbiol 2021;12:667718. [PMID: 34248876 DOI: 10.3389/fmicb.2021.667718] [Reference Citation Analysis]
134 Zhu Q, Rui K, Wang S, Tian J. Advances of Regulatory B Cells in Autoimmune Diseases. Front Immunol 2021;12:592914. [PMID: 33936028 DOI: 10.3389/fimmu.2021.592914] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
135 Leppkes M, Lindemann A, Gößwein S, Paulus S, Roth D, Hartung A, Liebing E, Zundler S, Gonzalez-Acera M, Patankar JV, Mascia F, Scheibe K, Hoffmann M, Uderhardt S, Schauer C, Foersch S, Neufert C, Vieth M, Schett G, Atreya R, Kühl AA, Bleich A, Becker C, Herrmann M, Neurath MF. Neutrophils prevent rectal bleeding in ulcerative colitis by peptidyl-arginine deiminase-4-dependent immunothrombosis. Gut 2021:gutjnl-2021-324725. [PMID: 34862250 DOI: 10.1136/gutjnl-2021-324725] [Reference Citation Analysis]
136 Quraishi MN, Shaheen W, Oo YH, Iqbal TH. Immunological Mechanisms Underpinning Faecal Microbiota Transplantation for the Treatment of Inflammatory Bowel Disease. Clin Exp Immunol. 2019;199:24-38. [PMID: 31777058 DOI: 10.1111/cei.13397] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 5.7] [Reference Citation Analysis]
137 Guzman-Prado Y, Samson O, Segal JP, Limdi JK, Hayee B. Vitamin D Therapy in Adults With Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis. Inflamm Bowel Dis 2020;26:1819-30. [PMID: 32385487 DOI: 10.1093/ibd/izaa087] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
138 Castner J, Amiri A, Rodriguez J, Huntington-Moskos L, Thompson LM, Zhao S, Polivka B. Advancing the symptom science model with environmental health. Public Health Nurs 2019;36:716-25. [PMID: 31310379 DOI: 10.1111/phn.12641] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
139 Schulz-Kuhnt A, Neurath MF, Wirtz S, Atreya I. Innate Lymphoid Cells as Regulators of Epithelial Integrity: Therapeutic Implications for Inflammatory Bowel Diseases. Front Med (Lausanne) 2021;8:656745. [PMID: 33869257 DOI: 10.3389/fmed.2021.656745] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
140 Caminero A, Pinto-Sanchez MI. Host immune interactions in chronic inflammatory gastrointestinal conditions. Curr Opin Gastroenterol 2020;36:479-84. [PMID: 32868507 DOI: 10.1097/MOG.0000000000000673] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
141 Rogler G, Scharl M, Spalinger M, Yilmaz B, Zaugg M, Hersberger M, Schreiner P, Biedermann L, Herfarth H. Diet and Inflammatory Bowel Disease: What Quality Standards Should Be Applied in Clinical and Laboratory Studies? Mol Nutr Food Res 2021;65:e2000514. [PMID: 33433954 DOI: 10.1002/mnfr.202000514] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
142 Seyed Tabib NS, Madgwick M, Sudhakar P, Verstockt B, Korcsmaros T, Vermeire S. Big data in IBD: big progress for clinical practice. Gut. 2020;69:1520-1532. [PMID: 32111636 DOI: 10.1136/gutjnl-2019-320065] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 10.0] [Reference Citation Analysis]
143 Martínez C, Juarranz Y, Gutiérrez-Cañas I, Carrión M, Pérez-García S, Villanueva-Romero R, Castro D, Lamana A, Mellado M, González-Álvaro I, Gomariz RP. A Clinical Approach for the Use of VIP Axis in Inflammatory and Autoimmune Diseases. Int J Mol Sci 2019;21:E65. [PMID: 31861827 DOI: 10.3390/ijms21010065] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
144 Vrdoljak J, Kumric M, Ticinovic Kurir T, Males I, Martinovic D, Vilovic M, Bozic J. Effects of Wine Components in Inflammatory Bowel Diseases. Molecules 2021;26:5891. [PMID: 34641434 DOI: 10.3390/molecules26195891] [Reference Citation Analysis]
145 Hartjes L, Ruland J. CARD9 Signaling in Intestinal Immune Homeostasis and Oncogenesis. Front Immunol 2019;10:419. [PMID: 30906296 DOI: 10.3389/fimmu.2019.00419] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
146 Arthur S, Palaniappan B, Afroz S, Sundaram U. Unique Regulation of Coupled NaCl Absorption by Inducible Nitric Oxide in a Spontaneous SAMP1/YitFc Mouse Model of Chronic Intestinal Inflammation. Inflamm Bowel Dis 2021:izab093. [PMID: 34019094 DOI: 10.1093/ibd/izab093] [Reference Citation Analysis]
147 Peng L, Gao X, Nie L, Xie J, Dai T, Shi C, Tao L, Wang Y, Tian Y, Sheng J. Astragalin Attenuates Dextran Sulfate Sodium (DSS)-Induced Acute Experimental Colitis by Alleviating Gut Microbiota Dysbiosis and Inhibiting NF-κB Activation in Mice. Front Immunol 2020;11:2058. [PMID: 33042117 DOI: 10.3389/fimmu.2020.02058] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
148 Barbara G, Barbaro MR, Fuschi D, Palombo M, Falangone F, Cremon C, Marasco G, Stanghellini V. Corrigendum: Inflammatory and Microbiota-Related Regulation of the Intestinal Epithelial Barrier. Front Nutr 2021;8:790387. [PMID: 34790692 DOI: 10.3389/fnut.2021.790387] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
149 Mendall M, Jensen CB, Ängquist LH, Baker JL, Jess T. Childhood growth and risk of inflammatory bowel disease: a population-based study of 317,030 children. Scand J Gastroenterol 2019;54:863-8. [PMID: 31294613 DOI: 10.1080/00365521.2019.1635201] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
150 Lochhead P, Khalili H, Sachs MC, Chan AT, Olén O, Ludvigsson JF. Association Between Statin Use and Inflammatory Bowel Diseases: Results from a Swedish, Nationwide, Population-based Case-control Study. J Crohns Colitis 2021;15:757-65. [PMID: 33216873 DOI: 10.1093/ecco-jcc/jjaa235] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
151 El-Baz AM, Khodir AE, Adel El-Sokkary MM, Shata A. The protective effect of Lactobacillus vs 5-aminosalicylic acid in ulcerative colitis model by modulation of gut microbiota and Nrf2/Ho-1 pathway. Life Sci. 2020;256:117927. [PMID: 32526285 DOI: 10.1016/j.lfs.2020.117927] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
152 Li T, Qiu Y, Yang HS, Li MY, Zhuang XJ, Zhang SH, Feng R, Chen BL, He Y, Zeng ZR, Chen MH. Systematic review and meta-analysis: Association of a pre-illness Western dietary pattern with the risk of developing inflammatory bowel disease. J Dig Dis 2020;21:362-71. [PMID: 32463159 DOI: 10.1111/1751-2980.12910] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 8.0] [Reference Citation Analysis]
153 Loktionov A. Eosinophils in the gastrointestinal tract and their role in the pathogenesis of major colorectal disorders. World J Gastroenterol 2019; 25(27): 3503-3526 [PMID: 31367153 DOI: 10.3748/wjg.v25.i27.3503] [Cited by in CrossRef: 31] [Cited by in F6Publishing: 23] [Article Influence: 10.3] [Reference Citation Analysis]
154 Sato M, Arakaki R, Tawara H, Tsunematsu T, Ishimaru N. Formation of Autoimmune Lesions Is Independent of Antibiotic Treatment in NOD Mice. Int J Mol Sci 2021;22:3239. [PMID: 33810172 DOI: 10.3390/ijms22063239] [Reference Citation Analysis]
155 Zhihua Y, Yulin T, Yibo W, Wei D, Yin C, Jiahao X, Runqiu J, Xuezhong X. Hypoxia decreases macrophage glycolysis and M1 percentage by targeting microRNA-30c and mTOR in human gastric cancer. Cancer Sci 2019;110:2368-77. [PMID: 31222863 DOI: 10.1111/cas.14110] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 6.3] [Reference Citation Analysis]
156 Battella S, Oliva S, Franchitti L, La Scaleia R, Soriani A, Isoldi S, Capuano C, Pighi C, Morrone S, Galandrini R, Santoni A, Palmieri G. Fine tuning of the DNAM-1/TIGIT/ligand axis in mucosal T cells and its dysregulation in pediatric inflammatory bowel diseases (IBD). Mucosal Immunol 2019;12:1358-69. [PMID: 31582819 DOI: 10.1038/s41385-019-0208-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
157 Turpin W, Goethel A, Bedrani L, Croitoru Mdcm K. Determinants of IBD Heritability: Genes, Bugs, and More. Inflamm Bowel Dis 2018;24:1133-48. [PMID: 29701818 DOI: 10.1093/ibd/izy085] [Cited by in Crossref: 45] [Cited by in F6Publishing: 38] [Article Influence: 15.0] [Reference Citation Analysis]
158 Yue B, Yu ZL, Lv C, Geng XL, Wang ZT, Dou W. Regulation of the intestinal microbiota: An emerging therapeutic strategy for inflammatory bowel disease. World J Gastroenterol 2020; 26(30): 4378-4393 [PMID: 32874052 DOI: 10.3748/wjg.v26.i30.4378] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
159 Meng X, Dunsmore G, Koleva P, Elloumi Y, Wu RY, Sutton RT, Ambrosio L, Hotte N, Nguyen V, Madsen KL, Dieleman LA, Chen H, Huang V, Elahi S. The Profile of Human Milk Metabolome, Cytokines, and Antibodies in Inflammatory Bowel Diseases Versus Healthy Mothers, and Potential Impact on the Newborn. J Crohns Colitis 2019;13:431-41. [PMID: 30418545 DOI: 10.1093/ecco-jcc/jjy186] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 6.7] [Reference Citation Analysis]
160 Kim YH, Pfaller B, Marson A, Yim HW, Huang V, Ito S. The risk of venous thromboembolism in women with inflammatory bowel disease during pregnancy and the postpartum period: A systematic review and meta-analysis. Medicine (Baltimore). 2019;98:e17309. [PMID: 31568016 DOI: 10.1097/md.0000000000017309] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
161 Hanawa Y, Higashiyama M, Kurihara C, Tanemoto R, Ito S, Mizoguchi A, Nishii S, Wada A, Inaba K, Sugihara N, Horiuchi K, Okada Y, Narimatsu K, Komoto S, Tomita K, Hokari R. Acesulfame potassium induces dysbiosis and intestinal injury with enhanced lymphocyte migration to intestinal mucosa. J Gastroenterol Hepatol 2021. [PMID: 34368996 DOI: 10.1111/jgh.15654] [Reference Citation Analysis]
162 Galipeau HJ, Caminero A, Turpin W, Bermudez-brito M, Santiago A, Libertucci J, Constante M, Raygoza Garay JA, Rueda G, Armstrong S, Clarizio A, Smith MI, Surette MG, Bercik P, Croitoru K, Verdu EF, Beck P, Bernstein C, Croitoru K, Dieleman L, Feagan B, Griffiths A, Guttman D, Jacobson K, Kaplan G, Krause DO, Madsen K, Marshall J, Moayyedi P, Ropeleski M, Seidman E, Silverberg M, Snapper S, Stadnyk A, Steinhart H, Surette M, Turner D, Walters T, Vallance B, Aumais G, Bitton A, Cino M, Critch J, Denson L, Deslandres C, El-matary W, Herfarth H, Higgins P, Huynh H, Hyams J, Mack D, Mcgrath J, Otley A, Panancionne R. Novel Fecal Biomarkers That Precede Clinical Diagnosis of Ulcerative Colitis. Gastroenterology 2021;160:1532-45. [DOI: 10.1053/j.gastro.2020.12.004] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
163 Dubinsky V, Reshef L, Bar N, Keizer D, Golan N, Rabinowitz K, Godny L, Yadgar K, Zonensain K, Tulchinsky H, Gophna U, Dotan I. Predominantly Antibiotic-resistant Intestinal Microbiome Persists in Patients With Pouchitis Who Respond to Antibiotic Therapy. Gastroenterology 2020;158:610-624.e13. [PMID: 31605691 DOI: 10.1053/j.gastro.2019.10.001] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 6.0] [Reference Citation Analysis]
164 Ge L, Lin Z, Le G, Hou L, Mao X, Liu S, Liu D, Gan F, Huang K. Nontoxic-dose deoxynivalenol aggravates lipopolysaccharides-induced inflammation and tight junction disorder in IPEC-J2 cells through activation of NF-κB and LC3B. Food Chem Toxicol 2020;145:111712. [PMID: 32877744 DOI: 10.1016/j.fct.2020.111712] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
165 Wang Y, Xie Q, Zhang Y, Ma W, Ning K, Xiang JY, Cui J, Xiang H. Combination of probiotics with different functions alleviate DSS-induced colitis by regulating intestinal microbiota, IL-10, and barrier function. Appl Microbiol Biotechnol 2020;104:335-49. [PMID: 31758237 DOI: 10.1007/s00253-019-10259-6] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 5.7] [Reference Citation Analysis]
166 Chen T, Shi N, Afzali A. Chemopreventive Effects of Strawberry and Black Raspberry on Colorectal Cancer in Inflammatory Bowel Disease. Nutrients 2019;11:E1261. [PMID: 31163684 DOI: 10.3390/nu11061261] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
167 Crawford MS, Nordgren TM, McCole DF. Every breath you take: Impacts of environmental dust exposure on intestinal barrier function-from the gut-lung axis to COVID-19. Am J Physiol Gastrointest Liver Physiol 2021;320:G586-600. [PMID: 33501887 DOI: 10.1152/ajpgi.00423.2020] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
168 Burisch J, Jess T. Does Eradication of Helicobacter Pylori Cause Inflammatory Bowel Disease? Clin Gastroenterol Hepatol 2019;17:1940-1. [PMID: 30768965 DOI: 10.1016/j.cgh.2019.02.013] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
169 Larussa T, Suraci E, Marasco R, Imeneo M, Abenavoli L, Luzza F. Self-Prescribed Dietary Restrictions are Common in Inflammatory Bowel Disease Patients and Are Associated with Low Bone Mineralization. Medicina (Kaunas) 2019;55:E507. [PMID: 31434334 DOI: 10.3390/medicina55080507] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
170 Deuring JJ, Li M, Cao W, Chen S, Wang W, de Haar C, van der Woude CJ, Peppelenbosch M. Pregnane X receptor activation constrains mucosal NF-κB activity in active inflammatory bowel disease. PLoS One 2019;14:e0221924. [PMID: 31581194 DOI: 10.1371/journal.pone.0221924] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
171 Wu M, Li P, An Y, Ren J, Yan D, Cui J, Li D, Li M, Wang M, Zhong G. Phloretin ameliorates dextran sulfate sodium-induced ulcerative colitis in mice by regulating the gut microbiota. Pharmacol Res 2019;150:104489. [PMID: 31689519 DOI: 10.1016/j.phrs.2019.104489] [Cited by in Crossref: 38] [Cited by in F6Publishing: 32] [Article Influence: 12.7] [Reference Citation Analysis]
172 Villeda-Ramírez MA, Meza-Guillen D, Barreto-Zúñiga R, Yamamoto-Furusho JK. ABCC7/CFTR Expression Is Associated with the Clinical Course of Ulcerative Colitis Patients. Gastroenterol Res Pract 2021;2021:5536563. [PMID: 34512749 DOI: 10.1155/2021/5536563] [Reference Citation Analysis]
173 Chen X, Liu R, Liu X, Xu C, Wang X. Protective Role of Coxsackie-Adenovirus Receptor in the Pathogenesis of Inflammatory Bowel Diseases. Biomed Res Int 2018;2018:7207268. [PMID: 30175139 DOI: 10.1155/2018/7207268] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
174 Manthey CF, Reher D, Huber S. [What is confirmed in the treatment of chronic inflammatory bowel diseases]. Internist (Berl) 2021. [PMID: 34727190 DOI: 10.1007/s00108-021-01207-6] [Reference Citation Analysis]
175 Hanić M, Trbojević-Akmačić I, Lauc G. Inflammatory bowel disease - glycomics perspective. Biochim Biophys Acta Gen Subj 2019;1863:1595-601. [PMID: 31276732 DOI: 10.1016/j.bbagen.2019.07.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
176 Ding S, Sun S, Ding R, Song S, Cao Y, Zhang L. Association between exposure to air pollutants and the risk of inflammatory bowel diseases visits. Environ Sci Pollut Res Int 2021. [PMID: 34669131 DOI: 10.1007/s11356-021-17009-0] [Reference Citation Analysis]
177 Tanaka H, Sakurai Y, Anindita J, Akita H. Development of lipid-like materials for RNA delivery based on intracellular environment-responsive membrane destabilization and spontaneous collapse. Adv Drug Deliv Rev 2020;154-155:210-26. [PMID: 32650040 DOI: 10.1016/j.addr.2020.07.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
178 Assadsangabi A, Evans CA, Corfe BM, Lobo A. Application of Proteomics to Inflammatory Bowel Disease Research: Current Status and Future Perspectives. Gastroenterol Res Pract 2019;2019:1426954. [PMID: 30774653 DOI: 10.1155/2019/1426954] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
179 Rashidian A, Akbarzadeh D, Asgarpanah J, Dehpour A. Bunium persicum essential oil reduced acetic acid-induced rat colitis through suppression of NF-κB pathway. Avicenna J Phytomed 2021;11:505-14. [PMID: 34745922 DOI: 10.22038/AJP.2021.18037] [Reference Citation Analysis]
180 Leppkes M, Neurath MF. Cytokines in inflammatory bowel diseases - Update 2020. Pharmacol Res 2020;158:104835. [PMID: 32416212 DOI: 10.1016/j.phrs.2020.104835] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 8.5] [Reference Citation Analysis]
181 Payros D, Ménard S, Laffitte J, Neves M, Tremblay-Franco M, Luo S, Fouche E, Snini SP, Theodorou V, Pinton P, Oswald IP. The food contaminant, deoxynivalenol, modulates the Thelper/Treg balance and increases inflammatory bowel diseases. Arch Toxicol 2020;94:3173-84. [PMID: 32617661 DOI: 10.1007/s00204-020-02817-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
182 Burrello C, Garavaglia F, Cribiù FM, Ercoli G, Bosari S, Caprioli F, Facciotti F. Short-term Oral Antibiotics Treatment Promotes Inflammatory Activation of Colonic Invariant Natural Killer T and Conventional CD4+ T Cells. Front Med (Lausanne) 2018;5:21. [PMID: 29468162 DOI: 10.3389/fmed.2018.00021] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 4.8] [Reference Citation Analysis]
183 Gubatan J, Levitte S, Patel A, Balabanis T, Wei MT, Sinha SR. Artificial intelligence applications in inflammatory bowel disease: Emerging technologies and future directions. World J Gastroenterol 2021; 27(17): 1920-1935 [PMID: 34007130 DOI: 10.3748/wjg.v27.i17.1920] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 5] [Article Influence: 10.0] [Reference Citation Analysis]
184 Hofseth LJ, Hebert JR, Chanda A, Chen H, Love BL, Pena MM, Murphy EA, Sajish M, Sheth A, Buckhaults PJ, Berger FG. Early-onset colorectal cancer: initial clues and current views. Nat Rev Gastroenterol Hepatol 2020;17:352-64. [PMID: 32086499 DOI: 10.1038/s41575-019-0253-4] [Cited by in Crossref: 44] [Cited by in F6Publishing: 42] [Article Influence: 22.0] [Reference Citation Analysis]
185 Lo CH, Khalili H, Song M, Lochhead P, Burke KE, Richter JM, Giovannucci EL, Chan AT, Ananthakrishnan AN. Healthy Lifestyle Is Associated With Reduced Mortality in Patients With Inflammatory Bowel Diseases. Clin Gastroenterol Hepatol 2021;19:87-95.e4. [PMID: 32142939 DOI: 10.1016/j.cgh.2020.02.047] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
186 Rodríguez-Lago I, Mesonero F, Hijos-Mallada G, Cañas M, Saldaña R, Savini C, Fernández S, Juliá B, Cea-Calvo L; ACCU, GETECCU, GETEII. Self-medication with analgesics reported by patients with ulcerative colitis: An anonymous survey. Gastroenterol Hepatol 2021:S0210-5705(21)00227-2. [PMID: 34400189 DOI: 10.1016/j.gastrohep.2021.07.009] [Reference Citation Analysis]
187 Li X, Wang Q, Ding L, Wang YX, Zhao ZD, Mao N, Wu CT, Wang H, Zhu H, Ning SB. Intercellular adhesion molecule-1 enhances the therapeutic effects of MSCs in a dextran sulfate sodium-induced colitis models by promoting MSCs homing to murine colons and spleens. Stem Cell Res Ther 2019;10:267. [PMID: 31443680 DOI: 10.1186/s13287-019-1384-9] [Cited by in Crossref: 13] [Cited by in F6Publishing: 17] [Article Influence: 4.3] [Reference Citation Analysis]
188 Yang J, Lim SY, Ko YS, Lee HY, Oh SW, Kim MG, Cho WY, Jo SK. Intestinal barrier disruption and dysregulated mucosal immunity contribute to kidney fibrosis in chronic kidney disease. Nephrology Dialysis Transplantation 2019;34:419-28. [DOI: 10.1093/ndt/gfy172] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 6.0] [Reference Citation Analysis]
189 Yalchin M, Segal JP, Mullish BH, Quraishi MN, Iqbal TH, Marchesi JR, Hart AL. Gaps in knowledge and future directions for the use of faecal microbiota transplant in the treatment of inflammatory bowel disease. Therap Adv Gastroenterol. 2019;12:1756284819891038. [PMID: 31803254 DOI: 10.1177/1756284819891038] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
190 Tian Z, Zhuang X, Zhao M, Zhuo S, Li X, Ma R, Li N, Liu C, Zhu Y, Tang C, Feng R, Chen M. Index-Based Dietary Patterns and Inflammatory Bowel Disease: A Systematic Review of Observational Studies. Adv Nutr 2021:nmab069. [PMID: 34157069 DOI: 10.1093/advances/nmab069] [Reference Citation Analysis]
191 Liso M, De Santis S, Verna G, Dicarlo M, Calasso M, Santino A, Gigante I, Eri R, Raveenthiraraj S, Sobolewski A, Palmitessa V, Lippolis A, Mastronardi M, Armentano R, Serino G, De Angelis M, Chieppa M. A Specific Mutation in Muc2 Determines Early Dysbiosis in Colitis-Prone Winnie Mice. Inflamm Bowel Dis 2020;26:546-56. [PMID: 31748792 DOI: 10.1093/ibd/izz279] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 13.0] [Reference Citation Analysis]
192 Schulthess J, Pandey S, Capitani M, Rue-Albrecht KC, Arnold I, Franchini F, Chomka A, Ilott NE, Johnston DGW, Pires E, McCullagh J, Sansom SN, Arancibia-Cárcamo CV, Uhlig HH, Powrie F. The Short Chain Fatty Acid Butyrate Imprints an Antimicrobial Program in Macrophages. Immunity 2019;50:432-445.e7. [PMID: 30683619 DOI: 10.1016/j.immuni.2018.12.018] [Cited by in Crossref: 225] [Cited by in F6Publishing: 220] [Article Influence: 75.0] [Reference Citation Analysis]
193 Kuang J, Huang Y, Hu J, Yu J, Zhou Q, Liu D. Exopolysaccharides from Bacillus amyloliquefaciens DMBA-K4 ameliorate dextran sodium sulfate-induced colitis via gut microbiota modulation. Journal of Functional Foods 2020;75:104212. [DOI: 10.1016/j.jff.2020.104212] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
194 Ran Z, An Y, Zhou J, Yang J, Zhang Y, Yang J, Wang L, Li X, Lu D, Zhong J, Song H, Qin X, Li R. Subchronic exposure to concentrated ambient PM2.5 perturbs gut and lung microbiota as well as metabolic profiles in mice. Environmental Pollution 2021;272:115987. [DOI: 10.1016/j.envpol.2020.115987] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
195 de Meij TGJ, de Groot EFJ, Peeters CFW, de Boer NKH, Kneepkens CMF, Eck A, Benninga MA, Savelkoul PHM, van Bodegraven AA, Budding AE. Variability of core microbiota in newly diagnosed treatment-naïve paediatric inflammatory bowel disease patients. PLoS One 2018;13:e0197649. [PMID: 30102706 DOI: 10.1371/journal.pone.0197649] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 4.8] [Reference Citation Analysis]
196 Shivaji UN, Nardone OM, Cannatelli R, Smith SC, Ghosh S, Iacucci M. Small molecule oral targeted therapies in ulcerative colitis. Lancet Gastroenterol Hepatol 2020;5:850-61. [PMID: 32171056 DOI: 10.1016/S2468-1253(19)30414-5] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
197 Luzentales-Simpson M, Pang YCF, Zhang A, Sousa JA, Sly LM. Vedolizumab: Potential Mechanisms of Action for Reducing Pathological Inflammation in Inflammatory Bowel Diseases. Front Cell Dev Biol 2021;9:612830. [PMID: 33614645 DOI: 10.3389/fcell.2021.612830] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
198 Melhem H, Kaya B, Ayata CK, Hruz P, Niess JH. Metabolite-Sensing G Protein-Coupled Receptors Connect the Diet-Microbiota-Metabolites Axis to Inflammatory Bowel Disease. Cells. 2019;8. [PMID: 31091682 DOI: 10.3390/cells8050450] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
199 Gubatan J, Chou ND, Nielsen OH, Moss AC. Systematic review with meta-analysis: association of vitamin D status with clinical outcomes in adult patients with inflammatory bowel disease. Aliment Pharmacol Ther 2019;50:1146-58. [PMID: 31647134 DOI: 10.1111/apt.15506] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 8.7] [Reference Citation Analysis]
200 Gu J, Shi Y, Zhu Y, Chen N, Wang H, Zhang Z, Chen T. Ambient air pollution and cause-specific risk of hospital admission in China: A nationwide time-series study. PLoS Med 2020;17:e1003188. [PMID: 32760064 DOI: 10.1371/journal.pmed.1003188] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 7.0] [Reference Citation Analysis]
201 Zundler S, Becker E, Spocinska M, Slawik M, Parga-Vidal L, Stark R, Wiendl M, Atreya R, Rath T, Leppkes M, Hildner K, López-Posadas R, Lukassen S, Ekici AB, Neufert C, Atreya I, van Gisbergen KPJM, Neurath MF. Hobit- and Blimp-1-driven CD4+ tissue-resident memory T cells control chronic intestinal inflammation. Nat Immunol 2019;20:288-300. [PMID: 30692620 DOI: 10.1038/s41590-018-0298-5] [Cited by in Crossref: 74] [Cited by in F6Publishing: 74] [Article Influence: 24.7] [Reference Citation Analysis]
202 Nazir S, Jankowski V, Bender G, Zewinger S, Rye KA, van der Vorst EPC. Interaction between high-density lipoproteins and inflammation: Function matters more than concentration! Adv Drug Deliv Rev 2020;159:94-119. [PMID: 33080259 DOI: 10.1016/j.addr.2020.10.006] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
203 Ren Q, Sun S, Zhang X. Redox-active nanoparticles for inflammatory bowel disease. Nano Res 2021;14:2535-57. [DOI: 10.1007/s12274-021-3303-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
204 Shen H, Zhang S, Zhao W, Ren S, Ke X, Gu Q, Tang Z, Xie J, Chen S, Chen Y, Zou J, Zhang L, Shen Z, Zheng K, Liu Y, Gu P, Cheng J, Hu J, Zhu L. Randomised clinical trial: Efficacy and safety of Qing-Chang-Hua-Shi granules in a multicenter, randomized, and double-blind clinical trial of patients with moderately active ulcerative colitis. Biomed Pharmacother 2021;139:111580. [PMID: 33857914 DOI: 10.1016/j.biopha.2021.111580] [Reference Citation Analysis]
205 González-Quilen C, Rodríguez-Gallego E, Beltrán-Debón R, Pinent M, Ardévol A, Blay MT, Terra X. Health-Promoting Properties of Proanthocyanidins for Intestinal Dysfunction. Nutrients 2020;12:E130. [PMID: 31906505 DOI: 10.3390/nu12010130] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 9.0] [Reference Citation Analysis]
206 Wrzosek L, Ciocan D, Borentain P, Spatz M, Puchois V, Hugot C, Ferrere G, Mayeur C, Perlemuter G, Cassard AM. Transplantation of human microbiota into conventional mice durably reshapes the gut microbiota. Sci Rep 2018;8:6854. [PMID: 29717179 DOI: 10.1038/s41598-018-25300-3] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 7.5] [Reference Citation Analysis]
207 Li T, Chen RR, Gong HP, Wang BF, Wu XX, Chen YQ, Huang ZM. FGL2 regulates IKK/NF-κB signaling in intestinal epithelial cells and lamina propria dendritic cells to attenuate dextran sulfate sodium-induced colitis. Mol Immunol 2020;117:84-93. [PMID: 31743856 DOI: 10.1016/j.molimm.2019.11.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
208 Luo S, Wen R, Wang Q, Zhao Z, Nong F, Fu Y, Huang S, Chen J, Zhou L, Luo X. Rhubarb Peony Decoction ameliorates ulcerative colitis in mice by regulating gut microbiota to restoring Th17/Treg balance. J Ethnopharmacol. 2019;231:39-49. [PMID: 30170079 DOI: 10.1016/j.jep.2018.08.033] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 7.3] [Reference Citation Analysis]
209 Day AS, Lemberg DA. Identification and diagnosis of Crohn disease and ulcerative colitis in children. J Paediatr Child Health 2020;56:1731-4. [PMID: 32468706 DOI: 10.1111/jpc.14925] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
210 Nishihara Y, Ogino H, Tanaka M, Ihara E, Fukaura K, Nishioka K, Chinen T, Tanaka Y, Nakayama J, Kang D, Ogawa Y. Mucosa-associated gut microbiota reflects clinical course of ulcerative colitis. Sci Rep 2021;11:13743. [PMID: 34215773 DOI: 10.1038/s41598-021-92870-0] [Reference Citation Analysis]
211 Han X, Ding S, Jiang H, Liu G. Roles of Macrophages in the Development and Treatment of Gut Inflammation. Front Cell Dev Biol 2021;9:625423. [PMID: 33738283 DOI: 10.3389/fcell.2021.625423] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
212 Garshol BF, Aamodt G, Madsen C, Vatn MH, Bengtson MB. The effect of nitrogen dioxide on low birth weight in women with inflammatory bowel disease: a Norwegian pregnancy cohort study (MoBa). Scand J Gastroenterol 2020;55:272-8. [PMID: 32064969 DOI: 10.1080/00365521.2020.1726446] [Reference Citation Analysis]
213 Fung TC. The microbiota-immune axis as a central mediator of gut-brain communication. Neurobiol Dis 2020;136:104714. [PMID: 31846737 DOI: 10.1016/j.nbd.2019.104714] [Cited by in Crossref: 32] [Cited by in F6Publishing: 25] [Article Influence: 10.7] [Reference Citation Analysis]
214 Bernstein CN. Review article: changes in the epidemiology of inflammatory bowel disease-clues for aetiology. Aliment Pharmacol Ther 2017;46:911-9. [PMID: 28949021 DOI: 10.1111/apt.14338] [Cited by in Crossref: 45] [Cited by in F6Publishing: 41] [Article Influence: 9.0] [Reference Citation Analysis]
215 M’koma A. The Multifactorial Etiopathogeneses Interplay of Inflammatory Bowel Disease: An Overview. GastrointestDisord 2018;1:75-105. [DOI: 10.3390/gidisord1010007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
216 Zhuang X, Liu C, Zhan S, Tian Z, Li N, Mao R, Zeng Z, Chen M. Gut Microbiota Profile in Pediatric Patients With Inflammatory Bowel Disease: A Systematic Review. Front Pediatr 2021;9:626232. [PMID: 33604319 DOI: 10.3389/fped.2021.626232] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
217 Dalzell AM, Ba’ath ME. Paediatric inflammatory bowel disease: review with a focus on practice in low- to middle-income countries. Paediatrics and International Child Health 2019;39:48-58. [DOI: 10.1080/20469047.2019.1575056] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
218 Bruckner RS, Nissim-Eliraz E, Marsiano N, Nir E, Shemesh H, Leutenegger M, Gottier C, Lang S, Spalinger MR, Leibl S, Rogler G, Yagel S, Scharl M, Shpigel NY. Transplantation of Human Intestine Into the Mouse: A Novel Platform for Study of Inflammatory Enterocutaneous Fistulas. J Crohns Colitis 2019;13:798-806. [PMID: 30590414 DOI: 10.1093/ecco-jcc/jjy226] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
219 Higashiyama M, Sugita A, Koganei K, Wanatabe K, Yokoyama Y, Uchino M, Nagahori M, Naganuma M, Bamba S, Kato S, Takeuchi K, Omori T, Takagi T, Matsumoto S, Nagasaka M, Sagami S, Kitamura K, Katsurada T, Sugimoto K, Takatsu N, Saruta M, Sakurai T, Watanabe K, Nakamura S, Suzuki Y, Hokari R. Management of elderly ulcerative colitis in Japan. J Gastroenterol 2019;54:571-86. [PMID: 31025187 DOI: 10.1007/s00535-019-01580-y] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
220 Bernstein CN. Is Antibiotic Use a Cause of IBD Worldwide? Inflamm Bowel Dis 2020;26:448-9. [PMID: 31265061 DOI: 10.1093/ibd/izz138] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
221 Liso M, De Santis S, Scarano A, Verna G, Dicarlo M, Galleggiante V, Campiglia P, Mastronardi M, Lippolis A, Vacca M, Sobolewski A, Serino G, Butelli E, De Angelis M, Martin C, Santino A, Chieppa M. A Bronze-Tomato Enriched Diet Affects the Intestinal Microbiome under Homeostatic and Inflammatory Conditions. Nutrients 2018;10:E1862. [PMID: 30513801 DOI: 10.3390/nu10121862] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 4.5] [Reference Citation Analysis]
222 Li X, Cui J, Yang H, Sun H, Lu R, Gao N, Meng Q, Wu S, Wu J, Aschner M, Chen R. Colonic Injuries Induced by Inhalational Exposure to Particulate-Matter Air Pollution. Adv Sci (Weinh) 2019;6:1900180. [PMID: 31179224 DOI: 10.1002/advs.201900180] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
223 Barbara G, Barbaro MR, Fuschi D, Palombo M, Falangone F, Cremon C, Marasco G, Stanghellini V. Inflammatory and Microbiota-Related Regulation of the Intestinal Epithelial Barrier. Front Nutr 2021;8:718356. [PMID: 34589512 DOI: 10.3389/fnut.2021.718356] [Reference Citation Analysis]
224 Scharrer S, Lissner D, Primas C, Reinisch W, Novacek G, Reinisch S, Papay P, Dejaco C, Vogelsang H, Miehsler W. Passive Smoking Increases the Risk for Intestinal Surgeries in Patients With Crohn's Disease. Inflamm Bowel Dis 2021;27:379-85. [PMID: 32529214 DOI: 10.1093/ibd/izaa117] [Reference Citation Analysis]
225 Neurath MF, Leppkes M. Resolution of ulcerative colitis. Semin Immunopathol 2019;41:747-56. [DOI: 10.1007/s00281-019-00751-6] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 5.7] [Reference Citation Analysis]
226 Rossi CM, Lenti MV, Merli S, Santacroce G, Di Sabatino A. Allergic manifestations in autoimmune gastrointestinal disorders. Autoimmun Rev 2021;:102958. [PMID: 34560305 DOI: 10.1016/j.autrev.2021.102958] [Reference Citation Analysis]
227 Xiao Y, Huang Q, Wu Z, Chen W. Roles of protein ubiquitination in inflammatory bowel disease. Immunobiology 2020;225:152026. [PMID: 33190004 DOI: 10.1016/j.imbio.2020.152026] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
228 Green N, Miller T, Suskind D, Lee D. A Review of Dietary Therapy for IBD and a Vision for the Future. Nutrients 2019;11:E947. [PMID: 31035465 DOI: 10.3390/nu11050947] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 6.3] [Reference Citation Analysis]
229 Burkard N, Meir M, Kannapin F, Otto C, Petzke M, Germer CT, Waschke J, Schlegel N. Desmoglein2 Regulates Claudin2 Expression by Sequestering PI-3-Kinase in Intestinal Epithelial Cells. Front Immunol 2021;12:756321. [PMID: 34659262 DOI: 10.3389/fimmu.2021.756321] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
230 Vuyyuru SK, Kedia S, Kalaivani M, Sahu P, Kante B, Kumar P, Ranjan MK, Makharia G, Ananthakrishnan A, Ahuja V. Efficacy and safety of fecal transplantation versus targeted therapies in ulcerative colitis: network meta-analysis. Future Microbiol 2021;16:1215-27. [PMID: 34590904 DOI: 10.2217/fmb-2020-0242] [Reference Citation Analysis]
231 Ho SM, Lewis JD, Mayer EA, Plevy SE, Chuang E, Rappaport SM, Croitoru K, Korzenik JR, Krischer J, Hyams JS, Judson R, Kellis M, Jerrett M, Miller GW, Grant ML, Shtraizent N, Honig G, Hurtado-Lorenzo A, Wu GD. Challenges in IBD Research: Environmental Triggers. Inflamm Bowel Dis 2019;25:S13-23. [PMID: 31095702 DOI: 10.1093/ibd/izz076] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 10.5] [Reference Citation Analysis]
232 Hua Y, Liu R, Lu M, Guan X, Zhuang S, Tian Y, Zhang Z, Cui L. Juglone regulates gut microbiota and Th17/Treg balance in DSS-induced ulcerative colitis. Int Immunopharmacol 2021;97:107683. [PMID: 33915494 DOI: 10.1016/j.intimp.2021.107683] [Reference Citation Analysis]
233 Toribio-Mateas M. Harnessing the Power of Microbiome Assessment Tools as Part of Neuroprotective Nutrition and Lifestyle Medicine Interventions. Microorganisms 2018;6:E35. [PMID: 29693607 DOI: 10.3390/microorganisms6020035] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.8] [Reference Citation Analysis]